Ph1b/2 multi-site open label three part study in combo of BNT324 with adv lung cancer
Phase
Phase I/II Clinical Trial
Condition(s)
Lung Cancer
Trial Number
06892548
Trial Status
OPEN
Study Overview
A Phase II multi-site open-label two-part trial to evaluate the efficacy safety pharmacokinetics and recommended combination dose of BNT324 with BNT327 in participants with advanced lung cancer. BNT324-01
